Glaxo Sales, Shares Benefit From Brexit Effects on Pound: ChartBy
GlaxoSmithKline Plc has gotten stronger as the British pound has gotten weaker. The U.K.’s biggest drugmaker gets the largest single chunk of its sales from the U.S., and the company can now convert those dollars into pounds at a more favorable rate. The London-based company will report quarterly results Wednesday.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.